Study of Mechanisms of Emotion Regulation in Alcohol-abstinent Patients
NCT ID: NCT02881983
Last Updated: 2017-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
112 participants
OBSERVATIONAL
2014-04-30
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Difficulties in assigning and identifying emotional states, or to regulate the emotional costs are recognized as one of the major factors of relapse. This study aimed to evaluate the emotion regulation processes, in short term (STA, after 1month of withdrawal) and long-term alcohol abstinent individuals (LTA, at least six months of abstinence), compared to healthy control participants (C) in a positive and negative emotion induction protocol.
Main aim:
Evaluating the emotional regulation deficits assessed with physiological indicators (heart rate variability, electrodermal response, pupil diameter) and clinically in presentations of visual stimuli to emotional value (positive, negative, neutral) in alcohol use disorder's (AUD) patients with short and long term abstinent compared to a control group of healthy subjects. The investigators are particularly interested in the evolution of heart rate variability considered as a good marker of vulnerability to AUD.
Secondary objectives:
Studying the relationships between physiological measures and clinical variables such as behavioral indicators and self-reported assessment of cognitive and emotional skills among the three groups (STA, LTA and C).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Neurophysiological Study of Sensory and Cognitive Processes in Healthy Children and Adults
NCT03182400
Ecological Momentary Assessment in Patients With Restless Legs Syndrome
NCT05695963
Emotional and Change-related Attention in Autism
NCT02160119
Deficits in Emotion Regulation Skills as a Maintaining Factor in Major Depressive Disorder
NCT01330485
Study of Cognitive and Emotional Disorders in Amyotrophic Lateral Sclerosis
NCT01530438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Participants were asked to evaluate the intensity and the valence of emotional stimuli.
In addition, a neurological evaluation, a clinical and cognitive assessment were performed.
Neurological, clinical and cognitive evaluation - Each participant had a clinical structured interview, a neurological evaluation, self-administered assessment (Hospital Anxiety \& Depression Scale, Emotional Skills Profile, Obsessive Compulsive Drinking Scale, and cognitive assessment (Montreal Cognitive Assessment).
Physiological assessment - The recording was performed for all participants during the presentation of pictures (static stimuli) or videos (dynamic stimuli) selected according to their high emotional intensity (positive, neutral and negative valence), representing human interactions. For each participant heart rate, electrodermal activity, and pupil diameter were recorded during three experimental conditions: rest, induction (presentation of stimuli) and after induction (recovery). Participants were asked to evaluate the intensity and valence of the pictures and videos using the Self-Assessment Manikin.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
STA group
Short-term alcohol abstinent patients (after 1 month of withdrawal)
the presentation of pictures (static stimuli) or videos (dynamic stimuli)
LTA group
Long-term alcohol abstinent patients (at least 6 months of abstinence)
the presentation of pictures (static stimuli) or videos (dynamic stimuli)
Control group
Healthy subjects
the presentation of pictures (static stimuli) or videos (dynamic stimuli)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
the presentation of pictures (static stimuli) or videos (dynamic stimuli)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* a diagnosis of severe alcohol use disorder (DSM5 criteria, 2013 confirmed by an addictonologist and a psychologist),
* successful completion of withdrawal,
* an intended treatment length of at least 1 month (for the STA group) or at least 6 months (for the LTA group).
For Control participants (C) :
\- social drinkers, and were recruited from the general population (e.g. at the university).
Exclusion Criteria
* neurological or cardiological disorders,
* taking medication that may act on heart rate or alter the regulation of body temperature or cognitive functions,
* with active co-dependence (except for tobacco)
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Lille
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier COTTENCIN, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Lille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CSAPA
Lille, , France
CHRU Lille, Fontan2
Lille, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-A00105-42
Identifier Type: OTHER
Identifier Source: secondary_id
2013_31
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.